Comparison of doxorubicin‐induced DNA damage in doxorubicin‐sensitive and ‐resistant P388 murine leukemia cells

International Journal of Cancer

Volumn 37, Issue 2, 1986, Pages 227-231

  Capranico, Giovanni ^a   Dasdia, Teresa ^a   Zunino, Franco ^a  

^a NATIONAL CANCER INSTITUTE   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

DOXORUBICIN; VERAPAMIL;

ANIMAL CELL; DNA DAMAGE; DOSE TIME EFFECT RELATION; DRUG EFFICACY; DRUG RESISTANCE; DRUG SENSITIVITY; DRUG TISSUE LEVEL; GENETIC ENGINEERING; HEREDITY; IN VITRO STUDY; INTOXICATION; LEUKEMIA CELL; LEUKEMIA P 388; METHODOLOGY; MOUSE; NONHUMAN; PRIORITY JOURNAL; REPRODUCTIVE TOXICITY; RETICULOENDOTHELIAL SYSTEM; THYMIDINE C 14; TOPICAL DRUG ADMINISTRATION;

ANIMAL; CELL LINE; COMPARATIVE STUDY; DNA; DOXORUBICIN; DRUG RESISTANCE; LEUKEMIA P388; LEUKEMIA, EXPERIMENTAL; MATHEMATICS; MICE; SUPPORT, NON-U.S. GOV'T; TIME FACTORS; VERAPAMIL;

EID: 0022602708     PISSN: 00207136     EISSN: 10970215     Source Type: Journal    
DOI: 10.1002/ijc.2910370210     Document Type: Article

References (25)

1. Cellular pharmacodynamics of several anthracycline antibiotics
2. Drug resistance in Chinese hamster lung and mouse tumor cells
3. Clinical pharmacology of cancer chemotherapy
4. The relationship between tumor mass and resistance to chemotherapy. Implications for surgical adjuvant treatment of cancer
5. The genetic origin of drug resistance in neoplasms: implications for systemic therapy
6. Uptake and retention of adriamycin and daunorubicin by sensitive and anthracycline‐resistant sublines of P388 leukemia
7. In vivo characteristics of resistance and cross‐resistance of an adriamycin‐resistant subline of P388 leukemia
8. Cell surface P‐glycoprotein associated with multidrug resistance in mammalian cell lines
9. Tumour cell resistance to anthracyclines–a review
10. Fractionation of DNA from mammalian cells by alkaline elution
11. Measurement of strand breaks and cross‐links by alkaline elution
12. Podophyllotoxin and VP‐16–213: a review of their divergent mechanisms of action
13. Inhibition of DNA and RNA metabolism by daunorubicin and adriamycin in L1210 mouse leukemia
14. Mechanism of antitumor drug action: poisoning of mammalian DNA topoisomerase II on DNA by 4′‐(9‐acridinylamino)‐methanesulfon‐m‐aniside
15. Restoration of doxorubicin responsiveness in doxorubicin‐resistant P388 murine leukaemia cells
16. Reversal of adriamycin resistance by verapamil in human ovarian cancer
17. Amplification of specific DNA sequences correlates with multi‐drug resistance in Chinese hamster cells
18. Role of topoisomerase II in mediating epipodophyllotoxin‐induced DNA cleavage
19. Qualitative and quantitative aspects of intercalator‐induced DNA strand breaks
20. Mechanisms of selective cytotoxicity of adriamycin, daunomycin and related anthracyclines
21. Carrier‐mediated transport of daunorubicin, adriamycin, and rubidazone in Ehrlich ascites tumour cells
22. Adriamycin‐induced DNA mediated by mammalian DNA topoisomerase II
23. Increased accumulation of vincristine and adriamycin in drugresistant tumor cells following incubation with calcium antagonists and calmodulin inhibitors
24. Enhancement of vincristine‐ and adriamycin‐induced cytotoxicity by verapamil in P388 leukemia and its resistant sublines to vincristine and adriamycin
25. The interaction of daunorubicin and doxorubicin with DNA and chromatin